Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-113,310
Closed -$2.82M 432
2025
Q4
$2.82M Buy
+113,310
New +$2.86M 0.54% 56
2025
Q3
Sell
-245,222
Closed -$5.94M 409
2025
Q2
$5.94M Buy
245,222
+185,134
+308% +$4.32M 1.24% 5
2025
Q1
$1.52M Buy
60,088
+28,072
+88% +$735K 0.45% 82
2024
Q4
$849K Sell
32,016
-74,740
-70% -$2.03M 0.36% 111
2024
Q3
$3.09M Buy
+106,756
New +$3.11M 1.23% 4
2024
Q2
Sell
-25,800
Closed -$716K 337
2024
Q1
$716K Buy
+25,800
New +$716K 0.38% 104
2023
Q4
Sell
-34,142
Closed -$1.13M 331
2023
Q3
$1.13M Buy
34,142
+12,089
+55% +$427K 0.63% 41
2023
Q2
$809K Sell
22,053
-300
-1% -$11.7K 0.46% 82
2023
Q1
$912K Buy
+22,353
New +$965K 0.8% 16
2022
Q2
Sell
-10,600
Closed -$549K 169
2022
Q1
$549K Buy
10,600
+1,600
+18% +$83K 1.21% 16
2021
Q4
$531K Sell
9,000
-619
-6% -$30.7K 1.28% 12
2021
Q3
$414K Sell
9,619
-5,271
-35% -$234K 0.89% 40
2021
Q2
$583K Buy
+14,890
New +$579K 0.99% 18
2020
Q1
Sell
-63,027
Closed -$2.34M 218
2019
Q4
$2.34M Buy
63,027
+2,468
+4% +$87.9K 0.93% 8
2019
Q3
$2.06M Buy
60,559
+14,355
+31% +$522K 0.94% 14
2019
Q2
$1.9M Buy
46,204
+5,820
+14% +$231K 0.71% 33
2019
Q1
$1.63M Buy
40,384
+30,610
+313% +$1.23M 0.65% 39
2018
Q4
$405K Buy
+9,774
New +$406K 0.27% 150

Other funds holding PFE

Machina Capital's PFE Position: Q1 2026 in Review

Machina Capital sold out of Pfizer (PFE) in Q1 2026, closing a stake of 113,310 shares — an estimated $2.82M sold.

Machina Capital first reported a position in PFE in Q4 2018 and held it in 18 quarters. The position peaked at $5.94M in Q2 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Machina Capital reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Machina Capital sold 113,310 Pfizer shares in Q1 2026, an estimated $2.82M.
  • Machina Capital first reported a position in Pfizer in Q4 2018 and held it in 18 quarters.
  • Machina Capital's Pfizer position peaked at $5.94M in Q2 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Machina Capital's 13F filing for Q1 2026, filed 13 May 2026.